Stocks · Health care · Biological Products, (No Diagnostic Substances)

Replimune Group, Inc.

REPL Clue Score21

United States Fiscal year ends March CIK 0001737953 Results filed 28 Oct 2026

Add to watchlist

What the insiders did Net selling

Bought (120 mo)

$33.57M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$86.93M

$963.96K on a plan · $10.70M straight out of an exercise

Sold at will

$75.27M

226 of 267 sales

Net

−$53.36M

−$41.70M against sales at will